Independent network The Bloc has appointed Jon Chapman as European Executive Creative Director. Chapman previously held ...
Almirall’s submission to extend its Marketing Authorisation Application (MAA) for Ebglyss (lebrikizumab) to treat moderate-to ...
How do we translate individual experiences into support that helps others and create support that feels personal but remains ...
Camena Bioscience, a pioneer in enzymatic DNA synthesis producing complex, high-fidelity gene constructs for AI-driven ...
Commercial pharma launches depend on confident, evidence-led decisions. Yet many launch teams are still working with ...
Following ASCO® 2026, Inizio's experts have shared their perspectives across three thought leadership articles, each ...
Independent healthcare communications consultancy POP Health has appointed Stephanie O’Hagan as Senior Director. O’Hagan has ...
Veradermics has announced positive topline results from its open-label phase 2 clinical trial (Study ‘207’) evaluating ...
New op-ed published by leaders from the Women’s Alzheimer’s Movement at Cleveland Clinic, Alzheimer’s Research UK and the ...
The phrase "patient-centered care" is tossed around freely in healthcare corporate boardrooms. Yet, for more than half the ...
As clinical trials accelerate, clear, accessible consent is essential to help participants understand, engage with and remain ...
AstraZeneca has entered into an exclusive licence agreement with Dizal Pharmaceutical for Zegfrovy (sunvozertinib), a novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results